IL142126A0 - Fentanyl composition for the treatment of acute pain - Google Patents

Fentanyl composition for the treatment of acute pain

Info

Publication number
IL142126A0
IL142126A0 IL14212699A IL14212699A IL142126A0 IL 142126 A0 IL142126 A0 IL 142126A0 IL 14212699 A IL14212699 A IL 14212699A IL 14212699 A IL14212699 A IL 14212699A IL 142126 A0 IL142126 A0 IL 142126A0
Authority
IL
Israel
Prior art keywords
composition
treatment
acute pain
fentanyl
essentially water
Prior art date
Application number
IL14212699A
Other languages
English (en)
Original Assignee
Diabact Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20412701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL142126(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diabact Ab filed Critical Diabact Ab
Publication of IL142126A0 publication Critical patent/IL142126A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14212699A 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain IL142126A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803239A SE9803239D0 (sv) 1998-09-24 1998-09-24 Composition for the treatment of acute pain
PCT/SE1999/001688 WO2000016751A1 (fr) 1998-09-24 1999-09-24 Composition de fentanyl pour le traitement des douleurs aigues

Publications (1)

Publication Number Publication Date
IL142126A0 true IL142126A0 (en) 2002-03-10

Family

ID=20412701

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14212699A IL142126A0 (en) 1998-09-24 1999-09-24 Fentanyl composition for the treatment of acute pain
IL142126A IL142126A (en) 1998-09-24 2001-03-20 Fentanyl preparation for the treatment of pain

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142126A IL142126A (en) 1998-09-24 2001-03-20 Fentanyl preparation for the treatment of pain

Country Status (26)

Country Link
US (1) US6759059B1 (fr)
EP (1) EP1115384B1 (fr)
JP (2) JP2002526440A (fr)
KR (1) KR100760531B1 (fr)
CN (1) CN1170524C (fr)
AT (1) ATE247950T1 (fr)
AU (1) AU764473B2 (fr)
BG (1) BG65363B1 (fr)
BR (1) BR9913948B1 (fr)
CA (1) CA2345064C (fr)
CZ (1) CZ301562B6 (fr)
DE (1) DE69910803T2 (fr)
DK (1) DK1115384T3 (fr)
EE (1) EE200100176A (fr)
ES (1) ES2207295T3 (fr)
HU (2) HU230688B1 (fr)
IL (2) IL142126A0 (fr)
NO (1) NO332228B1 (fr)
NZ (1) NZ510646A (fr)
PL (1) PL197078B1 (fr)
PT (1) PT1115384E (fr)
RU (1) RU2232580C2 (fr)
SE (1) SE9803239D0 (fr)
SK (1) SK283503B6 (fr)
TR (1) TR200100812T2 (fr)
WO (1) WO2000016751A1 (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
PL207845B1 (pl) 2000-07-31 2011-02-28 Nycomed Danmark As Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20030003113A1 (en) * 2001-06-29 2003-01-02 Lewandowski Leon J. Individualized addiction cessation therapy
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
CN100402084C (zh) * 2001-11-16 2008-07-16 兰多克斯实验室有限公司 检测或定量芬太尼或其类似物的代谢物的方法和试剂盒
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
ATE329594T1 (de) * 2003-01-31 2006-07-15 Orexo Ab Schnell wirkende pharmazeutische zusammensetzung
CA2516338A1 (fr) * 2003-03-11 2004-09-23 Arakis Ltd. Nouvelles compositions
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005065317A2 (fr) * 2003-12-31 2005-07-21 Cima Labs Inc. Forme posologique orale effervescente a base de fentanyl et procedes permettant d'administrer du fentanyl
AU2004311879B2 (en) 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
EP1708686B1 (fr) * 2003-12-31 2011-02-16 Cima Labs Inc. Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration
EP1715853A4 (fr) * 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20080248110A1 (en) * 2005-03-28 2008-10-09 Anders Pettersson Pharmaceutical Compositions Useful in the Treatment of Pain
NZ563979A (en) * 2005-05-25 2011-02-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
EP1968539A2 (fr) * 2005-12-13 2008-09-17 Biodelivery Sciences International, Inc. Dispositif resistant aux abus pour l'administration transmucosale de medicaments
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
DK1976521T3 (en) 2006-01-25 2015-04-27 Insys Therapeutics Inc Sublingual fentanyl spray
EP1837020A1 (fr) 2006-03-24 2007-09-26 Bioalliance Pharma Vehicule bioadhesif pour les muqueuses pour delivrer lentement des principes actifs
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20080090874A1 (en) * 2006-09-20 2008-04-17 Messina John C Jr Treatment of breakthrough pain in patients suffering from chronic low back pain
FR2907680B1 (fr) * 2006-10-27 2012-12-28 Scras Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
WO2008068471A1 (fr) * 2006-12-04 2008-06-12 Orexo Ab Nouvelle composition pharmaceutique non susceptible d'abus comprenant des opioïdes
JP2010518086A (ja) * 2007-02-09 2010-05-27 デュレクト コーポレーション スフェンタニルおよびナロキソンを含む経口腔投与製剤
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
WO2008133952A2 (fr) * 2007-04-24 2008-11-06 Cephalon, Inc. Méthodes de traitement par voie transmuqueuse chez des patients atteints de mucosite
US20100184785A1 (en) * 2007-06-06 2010-07-22 Basf Se Pharmaceutical formulation for the production of chewable tablets and lozenges
CA2698749C (fr) 2007-08-02 2017-05-23 Insys Therapeutics Inc. Aerosol sublingual de fentanyl
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2295046B1 (fr) * 2009-09-14 2012-12-19 Acino AG Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
WO2011041414A1 (fr) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Procédés et compositions de dissuasion d'abus
CN107811980B (zh) 2009-10-30 2021-06-18 Ix 生物医药有限公司 快速溶解固体剂型
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク． メトプロロールを含むアルコール耐性持続放出性経口剤形
US20120183580A1 (en) * 2011-01-13 2012-07-19 Theralpha Analgesic Composition for Transbuccal Administration
CA2845634C (fr) 2011-08-18 2021-07-13 Biodelivery Sciences International, Inc. Dispositifs mucoadhesifs anti-abus destines a administrer de la buprenorphine
EP3939569A1 (fr) 2011-09-19 2022-01-19 Orexo AB Nouvelle composition pharmaceutique résistant aux abus, pour le traitement de la dépendance aux opioïdes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
DE102012006396A1 (de) 2012-03-29 2013-10-02 Willy Rüsch GmbH Tracheostomietubus
ES2694644T3 (es) 2012-05-02 2018-12-26 Orexo Ab Nueva composición de alfentanilo para el tratamiento del dolor agudo
RU2673818C2 (ru) 2012-11-30 2018-11-30 Экьюра Фармасьютикалз, Инк. Саморегулируемое высвобождение фармацевтического ингредиента
WO2015065547A1 (fr) 2013-10-31 2015-05-07 Cima Labs Inc. Formes pharmaceutiques en granulés anti-abus à libération immédiate
WO2015119641A1 (fr) * 2014-02-07 2015-08-13 Scilabs Pharmaceuticals Systèmes d'administration sublinguale de médicaments non toxiques, entièrement naturels
US20160144528A1 (en) 2014-11-25 2016-05-26 Biodelivery Sciences International, Inc. Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
WO2020225773A1 (fr) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Formes posologiques dissuasives d'abus contenant de l'eskétamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action

Also Published As

Publication number Publication date
WO2000016751A1 (fr) 2000-03-30
SK4012001A3 (en) 2001-10-08
TR200100812T2 (tr) 2001-07-23
BR9913948A (pt) 2001-06-12
EE200100176A (et) 2002-08-15
DK1115384T3 (da) 2003-12-22
HU230688B1 (hu) 2017-09-28
AU6492899A (en) 2000-04-10
NO20011502L (no) 2001-03-23
PT1115384E (pt) 2004-01-30
AU764473B2 (en) 2003-08-21
US6759059B1 (en) 2004-07-06
KR20010075314A (ko) 2001-08-09
PL347467A1 (en) 2002-04-08
ES2207295T3 (es) 2004-05-16
JP2004269545A (ja) 2004-09-30
RU2232580C2 (ru) 2004-07-20
EP1115384A1 (fr) 2001-07-18
SE9803239D0 (sv) 1998-09-24
CA2345064A1 (fr) 2000-03-30
PL197078B1 (pl) 2008-02-29
HUP0103621A3 (en) 2005-05-30
CZ20011030A3 (cs) 2001-09-12
SK283503B6 (sk) 2003-08-05
CA2345064C (fr) 2008-05-27
BR9913948B1 (pt) 2011-02-08
HUP0103621A2 (hu) 2002-02-28
ATE247950T1 (de) 2003-09-15
EP1115384B1 (fr) 2003-08-27
DE69910803D1 (de) 2003-10-02
BG65363B1 (bg) 2008-04-30
JP2002526440A (ja) 2002-08-20
JP4478512B2 (ja) 2010-06-09
CN1328448A (zh) 2001-12-26
NO332228B1 (no) 2012-07-30
KR100760531B1 (ko) 2007-10-04
BG105380A (en) 2001-12-29
NO20011502D0 (no) 2001-03-23
CN1170524C (zh) 2004-10-13
DE69910803T2 (de) 2004-06-17
CZ301562B6 (cs) 2010-04-14
HU228992B1 (en) 2013-07-29
IL142126A (en) 2006-04-10
NZ510646A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
IL142126A0 (en) Fentanyl composition for the treatment of acute pain
MXPA01003068A (es) Composicion farmaceutica para el tratamiento de alteraciones agudas.
HK1080387A1 (en) A rapid-acing pharmaceutical composition
GB9700878D0 (en) Dosage forms and method for ameliorating male erectile dysfunction
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed